Tirzepatide

Tirz – Research Overview

Tirz is a dual agonist that acts on both GLP-1 and GIP receptors. In metabolic research, this combination is considered a significant advancement compared to substances that only affect one receptor.

• Synergistic Weight Management: Studied for its potential to reduce appetite and enhance satiety through two parallel mechanisms.
• Insulin Sensitivity: Investigated for its ability to improve glucose regulation and the body's insulin response.
• Metabolic Health: Analyzed for its impact on adipose tissue and lipid metabolism in the blood.

For research purposes only. This product is intended exclusively for scientific laboratory research and analytical purposes. Not for use in humans or animals.

Ultrapure Research Grade Peptide – guaranteed purity ≥ 98%.

Supplied in sterile vials suitable for laboratory use.

Manufactured according to strict quality standards.

All our peptides are provided strictly for research and laboratory use. No guidance is given regarding dosage, administration, or usage.